SALACTIN
Brand:
SALACTIN
Manufacturer:
NULIFE
Manufacturer Details
NULIFE
NULIFE PHARMACEUTICALS
PLOT NO 63
F2 BLOCK
MIDC PIMPRI
PUNE 411018
contactus@nulifepharma.com
Compositions:
Salicylic acid 16.7% w/v + Lactic acid 16.7%w/v + Flexible Collodion B.P q.s,
|
Strength
|
Rate
|
Packing Style
|
|
16.7%w/v+ 16.7%w/v
|
0.00
|
10ml paint
|
List of Related Indications:
List Of Drugs:
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
Interacting drugs- summary
Refer -Salicylates
Indication:
Interacting drugs- summary
Refer -Salicylates
Adverse Reaction:
Salicylate intoxification and death(increased risk with large dose, young children, high dose,frequency, presence of occulsion either dressing or natural skin folds). Dermatitis, allergic response, irritation, inflammation. Systemic absorption causes nausea, thirst,sweating, fatigue, fever and confusion.
Contra-Indications:
Hypersens, neonates, lactation, pregnancy. Special ptrecautions: None reported.
Patient Information:
1. For external use only- Avoid contact with eyes, face, genitals, mucous membranes and normal skin surrounding warts.
2. Medication may cause reddening of or scaling of skin when used on open skin lesions.
3. Contact with clothing, fabrics, plastics, wood, metal or other materials may cause damage, avoid contact.
Pharmacology/ Pharmacokinetics:
Pharmacology:
Salicylic acid produces desquamation of the horny layer of the skin, while not affecting the structure of the viable epidermis, by dissolving intercelluar cement substance.
Pharmacokinetics:
Peak serum levels occured within 5 hours of the topical application under occulsion.
Pregnancy and lactation:
Pregnancy No adequate and well controlled studies in pregnant wome. Use with caution.
